Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer's Ibrance on pace for blockbuster status after strong Q2
Pfizer's Ibrance on pace for blockbuster status after strong Q2
Pfizer's Ibrance on pace for blockbuster status after strong Q2
Submitted by
admin
on August 3, 2016 - 9:00am
Source:
BioPharma Dive
News Tags:
Pfizer
Ibrance
breast cancer
Headline:
Pfizer's Ibrance on pace for blockbuster status after strong Q2
Do Not Allow Advertisers to Use My Personal information
